PATENT CLAIM ANALYSIS

Application Number: 15918477
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2019-01
Patent Classification: ["514", "023000"]

Abstract:
The present invention relates to certain SGLT-2 inhibitors for treating and/or preventing oxidative stress, for example in patients with type 1 or type 2 diabetes, as well as to the use of such SGLT-2 inhibitors in treatment and/or prevention of cardiovascular diseases in patients, for example type 1 or type 2 diabetes patients. The present invention further relates to certain SGLT-2 inhibitors for treating and/or preventing a metabolic disorder and preventing, reducing the risk of or delaying the occurrence of a cardiovascular event in patients, for example patients with type 1 or type 2 diabetes.

Claim (Index 25):
The method according to  claim 1 , wherein the one or more other therapeutic substances are selected from other antidiabetic substances.

Metadata:
- Claim Count in Document: 74.0
- Percentile: 90.0
- Lexical Diversity: 2.26667
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14918713', '14918727', '15918401', '13833097', '13295174']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8066179380619919
- 35 USC 102 Novelty (BERT): 0.5659850012160035
- Combined Prediction Score: 0.7825546443773931
- Mean Citation Score: 401.606026
- Max Citation Score: 551.53827
- Similarity Product: 317.26540390943705

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test